# Resveratrol inhibits the replication of severe acute respiratory syndrome coronavirus 2 (<scp>SARS‐CoV</scp>‐2) in cultured Vero cells

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/resveratrol-inhibits-the-replication-of-severe-acute-respiratory-syndrome/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Minghui Yang,Jinli Wei,Ting Huang,Luping Lei,Chenguang Shen,Jinzhi Lai,Min Yang,Lei Liu,Yang Yang,Guoshi Liu,Yingxia Liu |
| Citations | 133 |
| DOI | 10.1002/ptr.6916 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ptr.6916 |
| OpenAlex ID | https://openalex.org/W3110248459 |
| PMID | 33222316 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Min Yang](https://scholariq.org/researchers/min-yang/)

## Paper journal

- [Phytotherapy Research](https://scholariq.org/journals/phytotherapy-research/)

## Paper primary topic

- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)

## Paper topics

- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)
- [Sirtuins and Resveratrol in Medicine](https://scholariq.org/topics/sirtuins-and-resveratrol-in-medicine/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
